Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  913 نتائج ل ""Neoadjuvant Therapy""

فلترة النتائج

Subject : esophageal neoplasms
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: A retrospective cohort study.

  • Authors : Jia W; Department of Science & Education, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, PR China.; Li C

Subjects: Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/therapy ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/mortality ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology

  • Source: PloS one [PLoS One] 2024 Nov 19; Vol. 19 (11), pp. e0304937. Date of Electronic Publication: 2024 Nov 19 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Tumor-Resident Microbiota-Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients.

  • Authors : Wu H; Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, P. R. China.; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610041, P. R. China.

Subjects: Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/therapy ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/pathology ; Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Nov; Vol. 11 (41), pp. e2309742. Date of Electronic Publication: 2024 Sep 13.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy.

  • Authors : Song Y; Key Laboratory of Clinical Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.; Qi Y

Subjects: Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/genetics ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Jul 31; Vol. 14 (1), pp. 17708. Date of Electronic Publication: 2024 Jul 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapy.

  • Authors : Qiu J; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.; Zhang Z

Subjects: Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/therapy ; Nomograms*

  • Source: World journal of surgical oncology [World J Surg Oncol] 2024 Jul 27; Vol. 22 (1), pp. 198. Date of Electronic Publication: 2024 Jul 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

[Neoadjuvant chemoradiotherapy versus neoadjuvant chemo-immunotherapy for locally advanced esophageal squamous cell carcinoma].

  • Authors : Wang XY; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou310022, China.; Shen HX

Subjects: Neoadjuvant Therapy* ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/therapy ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/pathology

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Nov 23; Vol. 46 (11), pp. 1058-1066.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer.

  • Authors : Lin Y; Department of Gastroenterology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, P.R. China.; Wang SF

Subjects: Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/therapy ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/mortality

  • Source: Scientific reports [Sci Rep] 2024 Nov 21; Vol. 14 (1), pp. 28898. Date of Electronic Publication: 2024 Nov 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.

  • Authors : Qi WX; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Proton-therapy, Shanghai, 201801, China.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: BMC cancer [BMC Cancer] 2024 Aug 20; Vol. 24 (1), pp. 1029. Date of Electronic Publication: 2024 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Neoadjuvant chemoimmunotherapy was associated with better short-term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy.

  • Authors : Duan X; Department of Minimally Invasive Esophageal Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Zhao F

Subjects: Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/therapy ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/mortality

  • Source: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (15), pp. e70113.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Esophageal surgical Apgar score (eSAS): A predictor for postoperative morbidity in patients undergoing neoadjuvant therapy and esophagectomy.

  • Authors : Wang Q; Department of Cardiothoracic Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.; Zhang C

Subjects: Esophagectomy*/Esophagectomy*/Esophagectomy*/adverse effects ; Esophagectomy*/Esophagectomy*/Esophagectomy*/methods ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/drug therapy

  • Source: Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (10), pp. 755-763. Date of Electronic Publication: 2024 Feb 23.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.

  • Authors : Shi JM; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.; Li N

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/therapy Adenocarcinoma Of Esophagus

  • Source: Scientific reports [Sci Rep] 2024 Mar 29; Vol. 14 (1), pp. 7522. Date of Electronic Publication: 2024 Mar 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  913 نتائج ل ""Neoadjuvant Therapy""